日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification

针对EGFR突变型非小细胞肺癌中的抑癌基因共突变:ACROSS2如何强化早期强化治疗的必要性

Gunturu, Krishna S; Khan, Hina; de Lima Lopes, Gilberto Jr

Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study

刚果民主共和国孕期感染猴痘病毒I型分支后母婴结局:一项汇总前瞻性队列研究

Vakaniaki, Emmanuel Hasivirwe; Barhishindi, Isaac; Mubiala, Ange; Malembaka, Espoir Bwenge; Braunack-Mayer, Lydia; Nganga, Bruce; Sabiti Nundu, Sabin; Brosius, Isabel; Bracke, Stefanie; Bangwen, Eugene; De Vos, Elise; Colebunders, Robert; Ngale, Mireille; Kayembe, Gabriel; Tshongo, Christian; Dilu, Ali; Tshimanga, Celestin; Biampata, Jean-Luc; Bugeme, Patrick Musole; Ntamabyaliro, Nsengi; Kirenga, Bruce; Wayengera, Misaki; Siewe Fodjo, Joseph Nelson; Lupande Mwenebitu, David; Rimoin, Anne W; Wawina-Bokalanga, Tony; Vercauteren, Koen; Mukadi-Bamuleka, Daniel; Muyembe-Tamfum, Jean-Jacques; Krasemann, Susanne; Kindrachuk, Jason; Azman, Andrew S; Nussenblatt, Veronique; Crozier, Ian; Dodd, Lori E; Tshiani-Mbaya, Olivier; Low, Nicola; Katoto, Patrick D M C; Mbala-Kingebeni, Placide; Liesenborghs, Laurens

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A

Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial

精准免疫疗法改善脓毒症预后:ImmunoSep随机临床试验

Giamarellos-Bourboulis, Evangelos J; Kotsaki, Antigone; Kotsamidi, Ioanna; Efthymiou, Aikaterini; Koutsoukou, Vasiliki; Ehler, Johannes; Paridou, Alexandra; Frantzeskaki, Frantzeska; Müller, Marcella C A; Pickkers, Peter; Meylan, Sylvain; Nikolopoulos, Ioannis; Lupse, Mihaela; Gavala, Alexandra; Vlachogianni, Glykeria; Solomonidi, Nicky; Alevizou, Antonia; Kondili, Eumorfia; Antoniadou, Eleni; Nakou, Maria; Markou, Nikolaos; Hatziagelaki, Erifili; Prekates, Athanassios; Komnos, Apostolos; Bakkerus, Lieke; Slim, Marleen A; Dalekos, George N; Karapanagiotou, Areti; Ktena, Sofia; De Pascale, Gennaro; Koulouras, Vassileios; Psarrakis, Christos; Massa, Eleni; Dakou, Konstantina; Pazvanti, Chrisoula; Ioakeimidou, Aikaterini; Tsangaris, Iraklis; Antonakos, Nikolaos; Vlaar, Alexander P J; Anisoglou, Souzana; Calandra, Thierry; Papaioannou, Vasilios; Myrianthefs, Pavlos; Patrani, Maria; Alamanos, Ioannis; Antonelli, Massimo; van der Meer, Jos W M; van der Poll, Tom; Wiersinga, W Joost; Ntaganou, Maria; Gkeka, Eleni; Bauer, Michael; Mouloudi, Eleni; Netea, Mihai G

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial

Evolocumab 可降低无已知显著动脉粥样硬化且患有糖尿病的患者首次发生重大心血管事件的风险:VESALIUS-CV 试验结果

Marston, Nicholas A; Bohula, Erin A; Bhatia, Ajay K; De Ferrari, Gaetano M; Leiter, Lawrence A; Nicolau, Jose C; Park, Jeong-Gun; Murphy, Sabina A; Walsh, Emileigh; Liu, Lyrica; Verma, Subodh; Sattar, Naveed; Nicholls, Stephen J; Lopez-Sendon, Jose; Gouni-Berthold, Ioanna; Tokgozoglu, Lale; Blankstein, Ron; Cyrille, Marcoli; da Silva Lima, Gabriel Paiva; Giugliano, Robert P; Sabatine, Marc S

Targeted Oxygen for Initial Resuscitation of Preterm Infants: The TORPIDO 30/60 Randomized Clinical Trial

针对早产儿初始复苏的靶向氧疗:TORPIDO 30/60 随机临床试验

Oei, Ju Lee; Kirby, Adrienne; Travadi, Javeed; Davis, Peter; Wright, Ian; Ghadge, Alpana; Yeung, Carbo; Cruz, Melinda; Keech, Anthony; Hague, Wendy; Lui, Kei; Vento, Maximo; Gordon, Adrienne; De Waal, Koert; Chaudhari, Tejasvi; Hong, Timothy Sui Loong; Morris, Scott; Kushnir, Alla; Bonney, Dennis; Tracy, Mark; Kumar, Kishore; Chhnia, Amitoj Singh; Baral, Vijay R; Muniyappa, Prasana; Cheah, Fook Choe; Sarnadgouda, Prashant; Rajadurai, Victor Samuel; Balakrishnan, Umamaheshwari; Oleti, Tejo Pratap; Aldecoa-Bilbao, Victoria; Couce, Maria-Luz; Collados, Caridad Tapia; Fernández, Raquel Escrig; Moliner, Elisender; Ruiz Gonzalez, Maria Dolores; Singhal, Mohit; Agrawal, Gopal; Singh, Jaykishore; Pal, Somalika; Nayya, Siddarth; Arora, Rohit; Amboiram, Prakash; Simes, John; Tarnow-Mordi, William

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial

肿瘤减瘤联合化疗治疗多器官转移性结直肠癌:ORCHESTRA随机临床试验

Gootjes, Elske C; Bakkerus, Lotte; Adhin, Anviti A; Zonderhuis, Barbara M; Versteeg, Kathelijn S; Tuynman, Jurriaan B; Meijerink, Martijn R; Haasbeek, Cornelis J A; de Wilt, Johannes H W; Grunhagen, Dirk J; Smit, Ewoud J; Primrose, John M; Bridgewater, John; van Meerten, Esther; de Groot, Jan-Willem B; Hendriks, Mathijs P; Oomen-de Hoop, Esther; Buffart, Tineke E; Verhoef, Cornelis; Verheul, Henk M W

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study

抗PD-1抗体penpulimab联合化疗治疗复发性或转移性鼻咽癌:一项随机、双盲3期研究

Huang, Shuang; Liu, Feng; Qu, Song; Chen, Lisha; Zhou, Ping; Qu, Shenhong; Ai, Xiaohong; Chen, Yong; Liu, Meilian; Wang, Rensheng; Chan, Kelvin Kw; Zhang, Peng; Hu, Chunhong; Wen, Jiyu; Zhang, Jian; Lin, Qin; Li, Xiaojiang; Gu, Kangsheng; Xiang, Li; Wang, Dongxia; Li, Jingao; Lin, Daren; Hu, Desheng; Ding, Jianwu; Wang, Siyang; Huang, Xiaoming; Wang, Lin; Jin, Feng; Pfister, David G; Mak, Milena Perez; Marchi, Pedro Rafael Martins de; Jiang, Yi; Yang, Haihua; Hu, Xiaoye; Liu, Tianrun; Wu, Dehua; Shreenivas, Aditya; Oliveira, Thiago Bueno de; Silva, Carlos Eduardo Baston; Alves, Gustavo Vasconcelos; Li, Xianming; Yao, Zhifang; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Chen, Xiaozhong; Hu, Chaosu; Xu, Tingting

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer

STRATEGIC-1:一项针对不可切除的 RAS/BRAF 野生型转移性结直肠癌的多线、随机、开放标签的 GERCOR-PRODIGE-39 III 期试验

Chibaudel, Benoist; Dourthe, Louis-Marie; André, Thierry; Henriques, Julie; Bourgeois, Vincent; Etienne, Pierre-Luc; Desramé, Jérôme; Carola, Elisabeth; Dupuis, Olivier; Baba-Hamed, Nabil; Auby, Dominique; Louvet, Christophe; Maillard, Emmanuel; Romano, Olivier; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Shacham-Shmueli, Einat; Bird, Brian Healey; Ghiringhelli, François; de Gramont, Aimery

Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.

胰腺导管腺癌的代谢靶向治疗依赖于糖酵解异质性。

Chianese Ugo, Papulino Chiara, Saggese Gerardo, Ali Ahmad, Ciotola Marianna, Lonardo Enza, Cortese Mirko, Favale Gregorio, Di Mauro Annabella, La Gioia Danila, Golino Valentina, Sommella Eduardo, Campiglia Pietro, Franco Renato, Ciardiello Fortunato, De Vita Ferdinando, Carafa Vincenzo, Altucci Lucia, Benedetti Rosaria